Cryptococcal Disease in Patients with the Acquired Immunodeficiency Syndrome

Diagnostic Features and Outcome of Treatment

  1. ABIGAIL ZUGER, M.D.;
  2. EDDIE LOUIE, M.D.;
  3. ROBERT S. HOLZMAN, M.D.;
  4. MICHAEL S. SIMBERKOFF, M.D.; and
  5. JAMES J. RAHAL, M.D.
  1. New York, New York

    Abstract

    Between 1 January 1981 and 1 December 1984, 34 of 396 patients with the acquired immunodeficiency syndrome (AIDS) developed cryptococcal infections. Twenty-six cases are reviewed. Twenty-two patients had brain or meningeal disease; the others had pulmonary disease (2 patients), pericarditis (1 patient), and antigenemia (1 patient). During treatment, 3 patients died of cryptococcosis and 3 died of other causes. Fifteen patients were followed for more than 6 weeks after treatment. Of 8 patients who received no additional amphotericin B, 4 had relapses and died of cryptococcosis within 6 months, 3 died of other causes, and 1 survived. Of 7 patients who received maintenance therapy with amphotericin B, none had relapses, 3 died of other causes, and 4 survived. Our data suggest that maintenance therapy with amphotericin may be needed to prevent relapse in patients with AIDS.

    Article and Author Information

    • ▸From the Infectious Disease Services of the Manhattan Veterans Administration and Bellevue Hospital Medical Centers, and the Department of Medicine, New York University School of Medicine, New York, New York.

    • ▸Requests for reprints should be addressed to James J. Rahal, M.D.; Division of Infectious Diseases, New York V. A. Medical Center, 24th Street and First Avenue; New York, NY 10010.

    « Previous | Next Article »Table of Contents